Novartis pays China's Baiyu $70M upfront, with $1.1B chaser, for small molecule cancer candidate 0 17.10.2024 15:19 Fiercebiotech.com Novartis pays China's Baiyu $70M upfront, with $1.1B chaser, for small molecule cancer candidate ntaylor Thu, 10/17/2024 - 08:19
